- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 12 x Y01: CHOLESTEROL HEMISUCCINATE(Non-covalent)
- 36 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)(Non-functional Binders)
POV.4: 4 residues within 4Å:- Chain A: M.435, S.448, G.449
- Ligands: POV.17
Ligand excluded by PLIPPOV.5: 18 residues within 4Å:- Chain A: C.494, W.495, A.498, V.499, L.502, Y.509, Q.513, D.525, Y.526, P.527
- Chain D: I.341, M.345, I.348, Y.349
- Ligands: Y01.3, POV.6, POV.41, POV.42
Ligand excluded by PLIPPOV.6: 17 residues within 4Å:- Chain A: F.416, G.423, P.424, L.428, K.484, M.485, G.488, M.491, R.492, C.494, W.495, R.584, L.592
- Chain D: M.474
- Ligands: Y01.2, Y01.3, POV.5
Ligand excluded by PLIPPOV.7: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPPOV.8: 10 residues within 4Å:- Chain A: F.343, C.347, L.373, L.386, E.389, T.439, M.440, R.443, L.444, M.454
Ligand excluded by PLIPPOV.9: 2 residues within 4Å:- Chain A: I.445, A.447
Ligand excluded by PLIPPOV.10: 12 residues within 4Å:- Chain A: R.326, A.334, L.337, F.472, Q.473, M.474, T.479
- Chain B: G.488, R.492, W.495, D.580
- Ligands: POV.11
Ligand excluded by PLIPPOV.11: 11 residues within 4Å:- Chain A: L.338, I.341, M.345, C.346, Y.349, K.381, D.382, R.385
- Ligands: Y01.1, POV.10, POV.22
Ligand excluded by PLIPPOV.13: 6 residues within 4Å:- Chain A: F.553
- Chain D: V.452
- Ligands: Y01.12, POV.47, POV.48, POV.49
Ligand excluded by PLIPPOV.17: 5 residues within 4Å:- Chain A: V.452, F.456
- Chain B: F.553
- Ligands: Y01.2, POV.4
Ligand excluded by PLIPPOV.21: 3 residues within 4Å:- Chain B: S.448, G.449
- Ligands: POV.30
Ligand excluded by PLIPPOV.22: 13 residues within 4Å:- Chain A: I.341, M.345, I.348, Y.349
- Chain B: W.495, L.502, Y.509, Y.524, D.525, Y.526, P.527
- Ligands: POV.11, Y01.20
Ligand excluded by PLIPPOV.23: 9 residues within 4Å:- Chain B: I.420, T.431, F.487, L.490, M.491
- Chain C: I.557, I.564
- Ligands: Y01.19, Y01.20
Ligand excluded by PLIPPOV.24: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPPOV.25: 12 residues within 4Å:- Chain B: F.343, C.346, C.347, Y.377, E.389, L.390, V.393, V.436, T.439, M.440, L.444, M.454
Ligand excluded by PLIPPOV.26: 1 residues within 4Å:- Chain B: I.445
Ligand excluded by PLIPPOV.27: 15 residues within 4Å:- Chain B: R.326, P.327, C.330, M.331, G.333, A.334, V.465, M.466, F.468, A.469, F.472
- Chain C: W.495, V.499
- Ligands: POV.28, POV.29
Ligand excluded by PLIPPOV.28: 16 residues within 4Å:- Chain B: L.337, I.341, I.348, Y.349
- Chain C: C.494, W.495, V.499, L.502, Y.509, D.525, Y.526, P.527
- Ligands: POV.27, POV.29, Y01.33, POV.35
Ligand excluded by PLIPPOV.29: 13 residues within 4Å:- Chain B: I.335, Y.339, I.341, M.345, C.346, Y.349, K.381, D.382, I.384, G.388
- Ligands: Y01.18, POV.27, POV.28
Ligand excluded by PLIPPOV.30: 8 residues within 4Å:- Chain B: G.449, V.451, V.452
- Chain C: F.553, M.554, I.557
- Ligands: Y01.20, POV.21
Ligand excluded by PLIPPOV.34: 2 residues within 4Å:- Chain C: S.448, G.449
Ligand excluded by PLIPPOV.35: 14 residues within 4Å:- Chain B: M.474
- Chain C: F.415, P.424, V.427, L.428, K.484, M.485, G.488, M.491, R.492, W.495
- Ligands: POV.28, Y01.32, Y01.33
Ligand excluded by PLIPPOV.36: 1 residues within 4Å:- Chain C: V.402
Ligand excluded by PLIPPOV.37: 10 residues within 4Å:- Chain C: F.343, C.346, C.347, L.386, E.389, T.392, T.439, R.443, L.444, M.454
Ligand excluded by PLIPPOV.38: 3 residues within 4Å:- Chain C: F.434, V.438, I.445
Ligand excluded by PLIPPOV.39: 11 residues within 4Å:- Chain C: L.337, L.338, I.341, C.342, M.345, Y.349, K.381, D.382, I.384, R.385
- Ligands: POV.48
Ligand excluded by PLIPPOV.41: 12 residues within 4Å:- Chain A: W.495
- Chain D: R.326, C.330, G.333, A.334, L.337, L.338, V.465, F.468, F.472
- Ligands: POV.5, POV.42
Ligand excluded by PLIPPOV.42: 14 residues within 4Å:- Chain D: L.338, M.345, C.346, Y.349, K.371, T.379, K.381, D.382, I.384, R.385, G.388
- Ligands: POV.5, POV.41, Y01.44
Ligand excluded by PLIPPOV.43: 2 residues within 4Å:- Chain C: V.452
- Chain D: F.553
Ligand excluded by PLIPPOV.46: 14 residues within 4Å:- Chain C: R.326, L.337, A.469, F.472, Q.473, M.474, G.476, P.477, T.479
- Chain D: F.487, G.488, D.489, M.491, R.492
Ligand excluded by PLIPPOV.47: 6 residues within 4Å:- Chain D: M.435, M.442, S.448, G.449
- Ligands: POV.13, POV.49
Ligand excluded by PLIPPOV.48: 14 residues within 4Å:- Chain C: I.341, M.345, I.348, Y.349
- Chain D: C.494, W.495, L.502, Y.509, D.525, Y.526, P.527
- Ligands: Y01.12, POV.13, POV.39
Ligand excluded by PLIPPOV.49: 12 residues within 4Å:- Chain A: I.557, A.561, I.564
- Chain D: I.420, F.456, F.487, L.490, M.491
- Ligands: Y01.12, POV.13, Y01.45, POV.47
Ligand excluded by PLIPPOV.50: 2 residues within 4Å:- Chain D: V.402
- Ligands: Y01.44
Ligand excluded by PLIPPOV.51: 13 residues within 4Å:- Chain D: F.343, C.346, C.347, L.373, Y.377, L.386, E.389, T.392, T.439, M.440, R.443, L.444, M.454
Ligand excluded by PLIPPOV.52: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIP- 2 x ZN: ZINC ION(Non-covalent)
ZN.14: 4 residues within 4Å:- Chain A: H.582, H.587
- Chain D: W.583, H.587
3 PLIP interactions:2 interactions with chain A, 1 interactions with chain D- Metal complexes: A:H.582, A:H.587, D:H.587
ZN.40: 4 residues within 4Å:- Chain B: W.583, H.587
- Chain C: H.582, H.587
3 PLIP interactions:1 interactions with chain B, 2 interactions with chain C- Metal complexes: B:H.587, C:H.582, C:H.587
- 1 x CA: CALCIUM ION(Non-covalent)
- 2 x GEN: GENISTEIN(Non-covalent)
GEN.16: 11 residues within 4Å:- Chain A: M.570, L.571, L.573, L.574
- Chain B: L.571, L.574
- Chain C: M.570, L.571, L.574
- Chain D: L.571, L.574
8 PLIP interactions:2 interactions with chain A, 4 interactions with chain C, 1 interactions with chain B, 1 interactions with chain D- Hydrophobic interactions: A:L.574, C:L.571, C:L.574, C:L.574, B:L.571, D:L.574
- Hydrogen bonds: A:M.570, C:M.570
GEN.53: 8 residues within 4Å:- Chain A: M.578, G.579
- Chain B: W.583
- Chain C: M.578
- Chain D: M.578, H.582, W.583, A.586
3 PLIP interactions:1 interactions with chain C, 2 interactions with chain D- Hydrophobic interactions: C:M.578, D:W.583, D:W.583
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Neuberger, A. et al., Structural mechanism of human oncochannel TRPV6 inhibition by the natural phytoestrogen genistein. Nat Commun (2023)
- Release Date
- 2023-05-24
- Peptides
- Transient receptor potential cation channel subfamily V member 6: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 12 x Y01: CHOLESTEROL HEMISUCCINATE(Non-covalent)
- 36 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)(Non-functional Binders)
- 2 x ZN: ZINC ION(Non-covalent)
- 1 x CA: CALCIUM ION(Non-covalent)
- 2 x GEN: GENISTEIN(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Neuberger, A. et al., Structural mechanism of human oncochannel TRPV6 inhibition by the natural phytoestrogen genistein. Nat Commun (2023)
- Release Date
- 2023-05-24
- Peptides
- Transient receptor potential cation channel subfamily V member 6: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D - Membrane
-
We predict this structure to be a membrane protein.